Veerhealth Care Limited (BOM:511523)
India · Delayed Price · Currency is INR 18.73
-0.30 (-1.58%)
At close: Feb 12, 2026
Veerhealth Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 179.24 | 166.71 | 132.23 | 132.73 | 96.26 | 105.8 |
Other Revenue | 8.87 | 6.13 | 9.9 | 9.41 | 11.73 | 7.9 |
| 188.11 | 172.84 | 142.13 | 142.14 | 107.99 | 113.7 | |
Revenue Growth (YoY) | 33.78% | 21.60% | -0.00% | 31.62% | -5.02% | -3.23% |
Cost of Revenue | 129.13 | 115.83 | 92.56 | 94.75 | 71.27 | 75.16 |
Gross Profit | 58.98 | 57.01 | 49.57 | 47.39 | 36.73 | 38.54 |
Selling, General & Admin | 17.98 | 17.04 | 15.38 | 12.87 | 11.79 | 8.28 |
Other Operating Expenses | 27.26 | 29.22 | 18.2 | 20.14 | 21.41 | 21.7 |
Operating Expenses | 56.33 | 55.34 | 40.69 | 39.22 | 38.44 | 34.65 |
Operating Income | 2.65 | 1.66 | 8.88 | 8.17 | -1.72 | 3.89 |
Interest Expense | -1.81 | -0.96 | - | - | -0.45 | -2.11 |
Interest & Investment Income | 6.05 | 6.05 | 3.99 | 2.99 | 4.94 | 4.07 |
Other Non Operating Income (Expenses) | -1.68 | -1.68 | -0.08 | -0.01 | -0.41 | -0.08 |
EBT Excluding Unusual Items | 5.2 | 5.08 | 12.8 | 11.14 | 2.38 | 5.77 |
Gain (Loss) on Sale of Assets | - | - | 0.02 | 0.03 | - | - |
Pretax Income | 5.2 | 5.08 | 12.82 | 11.17 | 2.38 | 5.77 |
Income Tax Expense | 0.56 | 1.16 | 8.75 | -4.65 | 3.11 | 1.98 |
Net Income | 4.64 | 3.91 | 4.06 | 15.82 | -0.74 | 3.79 |
Net Income to Common | 4.64 | 3.91 | 4.06 | 15.82 | -0.74 | 3.79 |
Net Income Growth | 407.66% | -3.62% | -74.33% | - | - | 19.13% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 14 | 14 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 14 | 14 |
Shares Change (YoY) | 0.27% | - | - | 44.20% | - | 0.00% |
EPS (Basic) | 0.23 | 0.20 | 0.20 | 0.79 | -0.05 | 0.27 |
EPS (Diluted) | 0.23 | 0.20 | 0.20 | 0.79 | -0.05 | 0.27 |
EPS Growth | 406.29% | -3.62% | -74.33% | - | - | 19.13% |
Free Cash Flow | -102.6 | -92.02 | 20.7 | -27.85 | 2.25 | 5.06 |
Free Cash Flow Per Share | -5.17 | -4.60 | 1.03 | -1.39 | 0.16 | 0.36 |
Gross Margin | 31.35% | 32.98% | 34.88% | 33.34% | 34.01% | 33.89% |
Operating Margin | 1.41% | 0.96% | 6.25% | 5.75% | -1.59% | 3.42% |
Profit Margin | 2.47% | 2.27% | 2.86% | 11.13% | -0.68% | 3.33% |
Free Cash Flow Margin | -54.54% | -53.24% | 14.56% | -19.59% | 2.08% | 4.45% |
EBITDA | 13.73 | 10.74 | 16 | 14.39 | 3.53 | 8.57 |
EBITDA Margin | 7.30% | 6.21% | 11.25% | 10.12% | 3.26% | 7.54% |
D&A For EBITDA | 11.09 | 9.08 | 7.12 | 6.22 | 5.24 | 4.68 |
EBIT | 2.65 | 1.66 | 8.88 | 8.17 | -1.72 | 3.89 |
EBIT Margin | 1.41% | 0.96% | 6.25% | 5.75% | -1.59% | 3.42% |
Effective Tax Rate | 10.84% | 22.92% | 68.31% | - | 130.98% | 34.25% |
Revenue as Reported | 194.16 | 178.89 | 146.13 | 145.13 | 112.94 | 117.77 |
Advertising Expenses | - | 1.26 | 2.28 | 3.67 | 2.92 | 0.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.